Yongfeng Sun

This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yongfeng Sun. Retrieved from https://idiyas.com/inventor/yongfeng-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 15.3

ph-index = 2

Forward Citations = 20(Granted Patents)

Company Filing History:

6 out of 3,978

Novartis Ag

patents

Years Active: 2017-2024

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11931363 - Triazolopyrimidine compounds and uses thereof (2024-03-19),

2. 11207325 - Triazolopyrimidine compounds and uses thereof (2021-12-28),

3. 10689378 - Triazolopyridine compounds and uses thereof (2020-06-23),

4. 10676479 - Imidazolepyridine compounds and uses thereof (2020-06-09),

5. 10220036 - Triazolopyrimidine compounds and uses thereof (2019-03-05),

6. 9580437 - Triazolopyrimidine compounds and uses thereof (2017-02-28),

Title: The Innovations of Yongfeng Sun: Pioneering Triazolopyrimidine Compounds

Introduction: Yongfeng Sun, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of pharmaceutical science. With a total of six patents to his name, he is recognized for his innovative work on novel compounds that have the potential to address serious medical conditions.

Latest Patents: Yongfeng's most recent patents include groundbreaking work on Triazolopyrimidine compounds. These compounds are characterized by a specific formula, which has been shown to be effective in treating diseases associated with PRC2 (Polycomb Repressive Complex 2)-mediated disorders. The details of these compounds underscore their importance in the pharmaceutical landscape, providing new avenues for therapeutic development.

Career Highlights: As a vital member of Novartis AG, Yongfeng Sun demonstrates exceptional ingenuity and dedication to advancing medical research. His relentless pursuit of innovation in drug development plays a crucial role in shaping the future of treatments for complex diseases.

Collaborations: Throughout his career, Yongfeng has worked alongside distinguished colleagues, including Ho Man Chan and Xiang-Ju Justin Gu. These collaborations have fostered a creative environment that has led to the successful development of several patented innovations.

Conclusion: Yongfeng Sun is a significant figure in the field of pharmaceuticals, renowned for his inventive contributions and practical applications of Triazolopyrimidine compounds. His work at Novartis AG and collaboration with talented professionals continue to drive advancements in medical science, paving the way for new therapies and solutions to challenging health issues.

Profile summary based on public USPTO records.